Methylphenidate reduces energy intake and dietary fat intake in adults: A mechanism of reduced reinforcing value of food?

American Journal of Clinical Nutrition

Volumn 86, Issue 2, 2007, Pages 308-315

  Goldfield, Gary S ^a,b,c   Lorello, Claudio ^b   Doucet, Éric ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c CARLETON UNIVERSITY   (Canada)

Author keywords

Dopamine; Eating; Energy intake; Food reinforcement; Methylphenidate; Obesity

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; FAT INTAKE; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; HUNGER; MACRONUTRIENT; MALE; RANDOMIZED CONTROLLED TRIAL; SATIETY;

EID: 34547896683     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/86.2.308     Document Type: Article

References (61)

1. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobeh Rev 1996;20:1-25.
2. Salamone JD. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav Brain Res 1994;61:117-33.
3. Saelens BE, Epstein LH. The reinforcing value of food in obese and non-obese women. Appetite 1996;27:41-50.
4. Epstein LH, Saelens BE. Behavioral economics of obesity: food intake and energy expenditure. In: Bickel WK, Vuchinich RE, eds. Reframing health behavior change with behavioral economics. Mahwah, NJ: Lawrence Erlbaum, 2000:293-311.
5. Johnson WG, Parry W, Drabman RS. The performance of obese and normal size children on a delay of gratification task. Addict Behav 1978;3:205-8.
6. Bonato DP, Boland FJ. Delay of gratification in obese children. Addict Behav 1983;8:71-4.
7. Drewnowski A, Holden-Wiltse J. Taste responses and food preferences in obese women: effects of weight cycling. Int J Obes Relat Metab Disord 1992;16:639-48.
8. Drewnowski A, Kurth C, Holden-Wiltse J, Saari J. Food preferences in human obesity: carbohydrates versus fats. Appetite 1992;18:207-21.
9. Drewnowski A, Krahn DD, Demitrack MA, Nairn K, Gosnell BA. Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Phys Behav 1992;51:371-9.
10. Epstein LH, Wright, SM, Paluch RA, et al. The relationship between food reinforcement and dopamine genotypes on food intake in smokers Am J Clin Nutr 2004;80:82-8.
11. Hanlon EC, Baldo BA, Sadeghian K, Kelley AE. Increases in food intake or food-seeking behavior induced by GABAergic, opioid, or dopaminergic stimulation of the nucleus accumbens: is it hunger? Psychopharmacology (Berl) 2004;172:241-7.
12. Martel P, Fantino M. Influence of the amount of food ingested on mesolimbic dopaminergic system activity: a microdialysis study. Pharmacol Biochem Behav 1996;55:297-302.
13. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 1998;28:309-69.
14. Bina KG, Cincotta AH. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology 2000;71:68-78.
15. Gillard ER, Dang DQ, Stanley BG. Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake. Brain Res 1993;628:128-36.
16. Cincotta AH, Tozzo E, Scislowski PW. Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice. Life Sci 1997;61:951-6.
17. Scislowski PW, Tozzo E, Zhang Y, Phaneuf S, Prevelige R, Cincotta AH. Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists. Int J Obes Relat Metab Disord 1999;23:425-31.
18. Noble EP, Noble RE, Ritchie T, et al. D2 dopamine receptor gene and obesity. Int J Eat Disord 1994;15:205-17.
19. 2 receptor (DRD2) gene. Mol Psychiatry 1996;1:325-35.
20. Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet 2001;357:354-7.
21. Epstein LH, Wright SM, Paluch RA, et al. Food hedonics and reinforcement as determinants of laboratory food intake in smokers. Phys Behav 2004;81:511-7.
22. Epstein LH, Jaroni JL, Paluch RA, et al. Dopamine transporter genotype as a risk factor for obesity in African-American smokers. Obes Res 2002;10:1232-40.
23. Rada P, Avena NM, Hoebel BG. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience 2005;134:737-44.
24. Avena NM, Rada PV, Moise N, Hoebel BG. Sucrose sham feeding on a binge schedule releases accumbens dopamine repeatedly and eliminates the acetylcholine satiety response. Neuroscience 2006;139:813-20.
25. Sobik L, Hutchison K, Craighead L. Cue-elicited craving for food: a fresh approach to the study of binge eating. Appetite 2005;44:253-61.
26. Shinohara M, Mizushima H, Hirano M, et al. Eating disorders with binge-eating behaviour are associated with the s allele of the 3′-UTR VNTR polymorphism of the dopamine transporter gene. J Psychiatry Neurosci 2004;29:134-7.
27. Seeman P, Madras BK. Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry 1998;3:386-96.
28. Volkow ND, Wang GJ, Fowler JS, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 1998;155:1325-31.
29. Kuczenski R, Segal DS. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 2001;296:876-83.
30. Wilens TE, Biederman J, Spencer TJ, Prince J. Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review. J Clin Psychopharmacol 1995;15:270-9.
31. Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Can Med Assoc J 2001;165:1475-88.
32. Schertz M, Adesman AR, Alfieri NE, Bienkowski RS. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Pediatrics 1996;98:763-9.
33. Martin WR, Sloan JW, Sapira JD, Jasinski DR. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Therap 1971;12:245-58.
34. Leddy JJ, Epstein LH, Jaroni JL, et al. Influence of methylphenidate on eating in obese men. Obes Res 2004;12:224-32.
35. McCann BS, Scheele L, Ward N, Roy-Byrne P. Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. J Neuropsychiatry Clin Neurosci 2000;12:240-5.
36. Rossini ED, O'Connor MA. Retrospective self-reported symptoms of attention-deficit hyperactivity disorder: reliability of the Wender Utah Rating Scale. Psychol Rep 1995;77:751-4.
37. Stein MA, Sandoval R, Szumowski E, et al. Psychometric characteristics of the Wender Utah Rating Scale (WURS): reliability and factor structure for men and women. Psychopharm Bull 1995;31:425-33.
38. First MB, Gibbon M, Spitzer RL, Williams JB. User's Guide for the SCID-IV. Structured clinical interview for DSM-IV axis 1 disorders. New York, NY: New York State Psychiatric Institute, Biometrics Research Department, 1996.
39. Beck AT, Steer RA, Brown GK. The Beck Depression Inventory-II (BDI-II). Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.
40. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985;29:71-83.
41. Hill AJ, Blundell JE. The effects of a high-protein or high-carbohydrate meal on subjective motivation to eat and food preferences. Nutr Behav 1986;3:133-44.
42. Karvetti RL, Knuts LR. Validity of the 24-hour dietary recall. J Am Diet Assoc 1985;85:1437-42.
43. Spielman AI. Chemosensory function and dysfunction. Crit Rev Oral Biol Med 1998;9:267-91.
44. Goldfield GS, Epstein LH, Davidson M, Saad F. Validation of a questionnaire measure of the relative reinforcing value of food. Eat Behav 2005;6:283-92.
45. Arvaniti K, Richard D, Tremblay A. Reproducibility of energy and macronutrient intake and related substrate oxidation rates in a buffet-type meal. Br J Nutr 2000;83:489-95.
46. Canadian Society for Exercise Physiology. The Canadian Physical Activity, Fitness and Lifestyle Approach. 3rd ed. Ottawa, Canada: Canadian Society for Exercise Physiology, 2003.
47. Pomerleau M, Imbeault P, Parker T, Doucet ET. Effects of exercise intensity on food intake and appetite in healthy women. Am J Clin Nutr 2004;80:1230-6.
48. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000;24:38-48.
49. Simmons JR, Smith GT, Hill KK. Validation of eating and dieting expectancy measures in two adolescent samples. Int J Eat Disord 2002;31:461-73.
50. Westenhoefer J, Stunkard AJ, Pudel VE. Validation of the flexible and rigid control dimensions of dietary restraint. Int J Eat Disord 1992;2:53-64.
51. Volkow ND, Wang G, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001;21:RC121.
52. Rolls BJ, Rolls ET, Rowe EA, Sweeney K. Sensory specific satiety in man. Phys Behav 1981;27:137-42.
53. Rolls BJ, Rowe EA, Rolls ET, Kingston B, Megson A, Gunary R. Variety in a meal enhances food intake in man. Phys Behav 1981;26:215-21.
54. Rolls BJ, Rowe EA, Rolls ET. How sensory properties in food affect human feeding behavior. Physiol Behav 1982;29:409-17.
55. Wang GJ, Volkow ND, Fowler JS. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 2002;6:601-9.
56. Davis C, Patte K, Levitan R, Reid C, Tweed S, Curtis C. From motivation to behaviour: a model of reward sensitivity, overeating, and food preferences in the risk profile for obesity. Appetite 2007;48:12-9.
57. Epstein LH, Leddy JJ. Food reinforcement. Appetite 2006;46:22-5.
58. Willett WC, Leibel RL. Dietary fat is not a major determinant of body fat. Am J Med 2002;113(supp):47S-59S.
59. Astrup A, Grunwald GK, Melanson EL Jr, Saris WH, Hill JO. The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Disord 2000;24:1545-52.
60. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? Lancet 1990;336:129-33.
61. Baptista T. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatra Scand 1999;100:3-16.